(EQQQ) Invesco EQQQ NASDAQ-100 - Ratings and Ratios
ETF, Shares, Growth, Index, Tracking, Diversification, Management
Description: EQQQ Invesco EQQQ NASDAQ-100
The Invesco EQQQ NASDAQ-100 UCITS ETF is designed to track the performance of the Morningstar US LM Brd Growth NR USD Index, providing investors with exposure to a broad range of US large-cap growth stocks. By replicating the index, the fund aims to deliver returns that closely correspond to the underlying indexs price and yield performance, before expenses.
As a US Large-Cap Growth Equity ETF listed on XETRA, EQQQ offers investors a diversified portfolio of prominent US companies, primarily from the technology and growth sectors. The funds underlying index is comprised of stocks that exhibit strong growth characteristics, making it an attractive option for investors seeking to capitalize on the growth potential of the US market.
Analyzing the funds technical data, we observe a bullish trend, with the short-term Simple Moving Average (SMA20) at 462.16 and the long-term SMA200 at 461.97, indicating a potential breakout. The Average True Range (ATR) of 7.94, or 1.70%, suggests moderate volatility. Given the current price of 467.15, we can anticipate a potential price movement within the range of 459.21 to 475.09, based on the ATR.
Fundamentally, the funds Assets Under Management (AUM) stand at 3969.68M EUR, indicating a sizable presence in the market. With the underlying index tracking the US large-cap growth segment, we can expect the fund to benefit from the long-term growth prospects of the US economy. Considering the current technical and fundamental landscape, we forecast a potential price target of 480-500 in the short to medium term, driven by the ongoing growth trend in the US technology and growth sectors.
To validate this forecast, we will continue to monitor the funds technical indicators, such as the SMA20 and SMA50, as well as the overall market conditions, to adjust our expectations accordingly. By combining technical and fundamental analysis, we can provide a more comprehensive understanding of the funds potential performance and identify opportunities for investors to capitalize on the growth potential of the US large-cap growth segment.
Additional Sources for EQQQ ETF
EQQQ ETF Overview
Market Cap in USD | 4,684m |
Category | US Large-Cap Growth Equity |
TER | 0.30% |
IPO / Inception | 2002-12-02 |
EQQQ ETF Ratings
Growth Rating | 66.5 |
Fundamental | - |
Dividend Rating | 54.5 |
Rel. Strength | -8.6 |
Analysts | - |
Fair Price Momentum | 446.03 EUR |
Fair Price DCF | - |
EQQQ Dividends
Dividend Yield 12m | 0.36% |
Yield on Cost 5y | 0.75% |
Annual Growth 5y | 11.83% |
Payout Consistency | 85.2% |
Payout Ratio | % |
EQQQ Growth Ratios
Growth Correlation 3m | 83.9% |
Growth Correlation 12m | 24% |
Growth Correlation 5y | 86.6% |
CAGR 5y | 15.57% |
CAGR/Max DD 5y | 0.50 |
Sharpe Ratio 12m | 0.21 |
Alpha | -11.96 |
Beta | 1.012 |
Volatility | 14.84% |
Current Volume | 5.3k |
Average Volume 20d | 4.8k |
As of July 03, 2025, the stock is trading at EUR 469.40 with a total of 5,265 shares traded.
Over the past week, the price has changed by +0.46%, over one month by +2.87%, over three months by +6.83% and over the past year by +3.96%.
Yes. Based on ValueRay's Analyses, Invesco EQQQ NASDAQ-100 (XETRA:EQQQ) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 66.51 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EQQQ is around 446.03 EUR . This means that EQQQ is currently overvalued and has a potential downside of -4.98%.
Invesco EQQQ NASDAQ-100 has no consensus analysts rating.
According to our own proprietary Forecast Model, EQQQ Invesco EQQQ NASDAQ-100 will be worth about 523.4 in July 2026. The stock is currently trading at 469.40. This means that the stock has a potential upside of +11.5%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 523.4 | 11.5% |